Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Regulatory changes significantly impacted the pharmaceuticals and healthcare sector during the half-year from March to September 2025. The government's decision to reform the Goods and Services Tax (GST) regime for the first time since its ...
View more details
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
The Philippines' healthcare system comprises both public and private components. Public healthcare is devolved to local government units, with the central government operating only a handful of tertiary care and specialist health facilities. ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
The CEE pharmaceutical and healthcare sector demonstrates remarkable resilience amid regional economic pressures, with each country adopting distinct strategies to address similar challenges. The overall market continues its growth trajectory, though ...
View more details
Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...
View more details
Poland's healthcare and pharmaceutical sector is dynamic and rapidly evolving, marked by innovation, resilience, and a growing global presence despite substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has ...
View more details
India's pharmaceutical and healthcare sector is world-renowned. India's reputation as the "pharmacy of the world" was earned from its extensive production of generic medications and vaccines. For instance, Serum Institute of India, a vaccine producer ...
View more details